Skip to content
Search

Latest Stories

Food labelled as ‘vegan’ may not always be safe to eat: FSA warns people with allergies

Food labelled as ‘vegan’ may not always be safe to eat: FSA warns people with allergies

More than 60 per cent of people who are allergic to animal-based products believe that food  labelled ‘vegan’ is safe to eat   

The Food Standards Agency (FSA) has launched a campaign to caution people with food allergies about the risk of products labelled as ‘vegan’.


People who have an allergy to milk, eggs, fish and crustaceans or molluscs are encouraged to always check for a precautionary allergen statement such as ‘may contain’ on products labelled 'vegan' before consuming the food.

The launch of the campaign comes in the wake of recent research findings by the FSA that 62 per cent of individuals with reactions to animal-based products or who buy for someone with allergies were confident that products labelled ‘vegan’ are safe to eat. This is “incorrect” and may put them at risk, the agency said.

The FSA study found that 54 per cent of people who experience reactions to animal-based products and 53 per cent of those purchasing for someone with a food hypersensitivity to animal-origin products have used vegan labelling to determine the safety of packaged food on at least some occasions.

Nearly 30 per cent of these buyers were unaware that they should check for a precautionary allergen label on vegan products to assess the safety of the food.

Emily Miles, CEO of the FSA, expressed concern that a significant number of individuals who are allergic to animal-based products believe that food labelled as 'Vegan' is safe for them.

She cautioned that there is a risk of cross-contamination with animal-based allergens in vegan and plant-based products if they are produced in the same factory as animal-based products.

The campaign also explains the difference between a free-from label and a vegan or plant-based label.  To use a free-from label, food establishments must follow strict processes to eliminate the possibility of cross-contamination, ensuring that the products do not contain any of the allergen they claim to be free from.

Claire Ogley, head of campaigns, policy and research at the Vegan Society, highlighted the importance of clear labelling to people who follow a vegan diet, especially for people with food allergies.

Ogley cautioned that a ‘vegan’ label does not necessarily mean the product is ‘allergen-free’ and advised people with allergies to always check the allergen labelling on products before consuming them.

Allergy UK, Anaphylaxis UK and the Natasha Allergy Research Foundation are supporting the campaign.

Recently, the FSA updated its food labelling technical guidance for food businesses, advising them to use a Precautionary Allergen Label (PAL) alongside a vegan label, if cross-contamination can’t be ruled out.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less